It was discovered that females had a “50% higher risk of developing cirrhosis,” scarring of the liver, and had a higher rate of liver mortality than their male counterparts, researchers said.

SYNCHRONY Outcomes in patients with compensated cirrhosis (F4) due to MASH, SYNCHRONY Histology in patients with pre-cirrhotic (F2-F3 fibrosis) MASH, and SYNCHRONY Real-World in patients with MASH ...

Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials in patients with non-cirrhotic (F2-F3) and compensated cirrhotic (F4) metabolic dysfunction-associated steatohepatitis (MASH) continue to ...

This is especially the case if you have liver damage (cirrhosis). Unfortunately, people with severe liver damage may be too unwell to have treatment for their cancer. Your doctor can use different ...

Reported unprecedented, statistically significant reversal of compensated cirrhosis (F4 ... Analysis of biopsies by AI-based Digital Pathology (qFibrosis®, Histoindex) corroborated the extent ...

The liver had a micronodular cirrhosis with evidence of marked portal hypertension. Histologically, there were areas of multiacinar collapse with occasional islands of less damaged tissue, numerous ...